Obesity+1
Not recruitingStudy on the Effects of RO7204239 and Tirzepatide for Weight Loss in Patients with Obesity or Overweight with a Weight-Related Health Issue
Study on the Effects of RO7204239 and Tirzepatide for Weight Loss in Patients with Obesity or Overweight with a Weight-Related Health Issue
- Disease:ObesityOverweight
- Substances:TirzepatideHumanised Igg1 Monoclonal Antibody Against Human Latent Myostatin
Poland- Participants:18–64 years · 65+ years
- Substances:Tirzepatide
- Sponsor:F. Hoffmann-La Roche AG










